30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Glenn Sblendorio

Track

Insider profile

Currently holds positions in Amicus Therapeutics Inc, Intercept Pharmaceuticals Inc and Iveric Bio Inc

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Amicus Therapeutics Inc June 1, 2006 -
Independent Director Intercept Pharmaceuticals Inc Feb. 17, 2014 -
President, Chief Executive Officer, Director Iveric Bio Inc April 1, 2017 -
President, Chief Financial Officer, Treasurer Iveric Bio Inc Jan. 29, 2017 - April 1, 2017
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer Iveric Bio Inc April 1, 2016 - Jan. 29, 2017
Independent Director Iveric Bio Inc July 1, 2013 - April 1, 2016
President, Chief Financial Officer, Director Medicines Co Feb. 1, 2012 - Jan. 1, 2016
Director Medicines Co July 26, 2011 - Feb. 1, 2012
Glenn Sblendorio's trades of Iveric Bio Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-04 2023-01-03
S Sale
8,558 +47.1%
325.99
US$2,300,600 		8,558 +47.1% 325.99 US$2,300,600
2022-12-20 2022-12-19
S Sale
86,038 -23.6%
375.49
US$4,863,054 		86,038 -23.6% 375.49 US$4,863,054
2022-11-04 2022-11-02
PlS Planned sale
45,394 -35.3%
59.92
US$213,285 		45,394 -35.3% 59.92 US$213,285
2022-04-06 2022-04-04
PlS Planned sale
50,000 -17.9%
18.76
US$937,805 		50,000 -17.9% 18.76 US$937,805
2022-04-01 2022-04-01
PlS Planned sale
40,756 -12.7%
17.50
US$713,230 		40,756 -12.7% 17.50 US$713,230
2022-04-01 2022-03-31
PlS Planned sale
1,400 -0.5%
17.02
US$23,828 		1,400 -0.5% 17.02 US$23,828
2022-04-01 2022-03-30
PlS Planned sale
1,213 -0.4%
17.00
US$20,626 		1,213 -0.4% 17.00 US$20,626
2022-03-29 2022-03-25
PlS Planned sale
18,775 -6.3%
17.06
US$320,302 		18,775 -6.3% 17.06 US$320,302
2022-03-22 2022-03-18
PlS Planned sale
3,479 -1.2%
17.00
US$59,145 		3,479 -1.2% 17.00 US$59,145
2022-01-03 2021-12-31
PlS Planned sale
801 -0.3%
17.01
US$13,621 		801 -0.3% 17.01 US$13,621
2022-01-03 2021-12-30
PlS Planned sale
100 -0.0%
17.01
US$1,701 		100 -0.0% 17.01 US$1,701
2021-12-21 2021-12-20
S Sale
18,524 -5.2%
15.44
US$286,075 		18,524 -5.2% 15.44 US$286,075
2021-12-14 2021-12-13
S Sale
8,293 -2.5%
14.74
US$122,279 		8,293 -2.5% 14.74 US$122,279
2019-05-13 2019-05-10
B Purchase
25,000 +36.7%
1.48
US$37,000 		25,000 +36.7% 1.48 US$37,000
2019-04-03 2019-04-02
S Sale
6,914 -9.2%
1.43
US$9,887 		6,914 -9.2% 1.43 US$9,887
2018-04-03 2018-04-02
S Sale
6,838 -12.4%
2.69
US$18,394 		6,838 -12.4% 2.69 US$18,394
2018-01-03 2018-01-02
S Sale
8,089 -18.1%
3.19
US$25,804 		8,089 -18.1% 3.19 US$25,804
2017-07-05 2017-07-05
S Sale
7,828 -24.5%
2.58
US$20,196 		7,828 -24.5% 2.58 US$20,196
2016-06-03 2016-06-02
S Sale
671 -38.3%
57.20
US$38,381 		671 -38.3% 57.20 US$38,381
2004-10-15 2004-10-14
US Oldtech Inc (EYET)
S Sale
7,500 -100.0%
41.25
US$309,375 		7,500 -100.0% 41.25 US$309,375